Literature DB >> 1398738

Liposome mediated affection of monocytes.

I Huitinga1, J G Damoiseaux, N van Rooijen, E A Döpp, C D Dijkstra.   

Abstract

Dichloromethylene diphosphonate (Cl2MDP) enclosed in liposomes, when injected intravenously, selectively eliminates all phagocytizing macrophages that are in direct contact with the blood circulation of the spleen and the liver. We examined whether Cl2MDP containing liposomes affect, in addition, rat monocytes and bone marrow macrophage precursors (BMMP's). In addition to Phosphatidylcholine-Cholesterol liposomes (PC liposomes), we also used mannosylated PC liposomes (PCMAN liposomes), which are reported to bind more efficiently to macrophages. Monocytes appeared to be affected 24 h after injections of 2 ml of Cl2MDP containing PC as well as PCMAN liposomes. In addition, almost no macrophages could be detected in one week cultures of blood leukocytes isolated from these animals; cultures from control animals contained +/- 50% macrophages. Bone marrow macrophage precursors did not appear to be affected.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398738     DOI: 10.1016/S0171-2985(11)80313-X

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  15 in total

1.  Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.

Authors:  Christopher K Cote; Nico Van Rooijen; Susan L Welkos
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Role of macrophages during Theiler's virus infection.

Authors:  C P Rossi; M Delcroix; I Huitinga; A McAllister; N van Rooijen; E Claassen; M Brahic
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

3.  Roles of macrophages in measles virus infection of genetically modified mice.

Authors:  B Roscic-Mrkic; R A Schwendener; B Odermatt; A Zuniga; J Pavlovic; M A Billeter; R Cattaneo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Expression of the mannose receptor CD206 in HIV and SIV encephalitis: a phenotypic switch of brain perivascular macrophages with virus infection.

Authors:  Gerard E Holder; Christopher M McGary; Edward M Johnson; Rubo Zheng; Vijay T John; Chie Sugimoto; Marcelo J Kuroda; Woong-Ki Kim
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-22       Impact factor: 4.147

5.  Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.

Authors:  George P Christophi; Paul T Massa
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

6.  Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant.

Authors:  J Biewenga; M B van der Ende; L F Krist; A Borst; M Ghufron; N van Rooijen
Journal:  Cell Tissue Res       Date:  1995-04       Impact factor: 5.249

7.  West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice.

Authors:  D Ben-Nathan; I Huitinga; S Lustig; N van Rooijen; D Kobiler
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease.

Authors:  George P Christophi; Chad A Hudson; Michael Panos; Ross C Gruber; Paul T Massa
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

9.  In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis.

Authors:  Oumaïma Ibrahim-Granet; Grégory Jouvion; Tobias M Hohl; Sabrina Droin-Bergère; François Philippart; Oh Yoen Kim; Minou Adib-Conquy; Reto Schwendener; Jean-Marc Cavaillon; Matthias Brock
Journal:  BMC Microbiol       Date:  2010-04-08       Impact factor: 3.605

10.  Targeted anti-inflammatory systemic therapy for restenosis: the Biorest Liposomal Alendronate with Stenting sTudy (BLAST)-a double blind, randomized clinical trial.

Authors:  Shmuel Banai; Ariel Finkelstein; Yaron Almagor; Abid Assali; Yonathan Hasin; Uri Rosenschein; Patricia Apruzzese; Alexandra J Lansky; Teruyoshi Kume; Elazer R Edelman
Journal:  Am Heart J       Date:  2012-12-11       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.